Replies to post #6000 on Vericel Corp. (VCEL)

[hurley cruppers]

Regenerative advanced therapies are eligible for priority review and accelerated approval. It’s our hope that by investigating alternative regulatory paths for ixmyelocel-T will increase the likelihood of accessing the non-dilutive means to commercialize the program. So in summary, we have built a strong foundation for our next phase of growth.

[hurley cruppers]

Wonder if we will get any Upgrades from these 3 conferences going into Tuesday